SELECTIVE DEPLETION OF TUMOR-SPECIFIC REGULATORY T CELLS IN COMBINATION WITH LOW DOSE CHEMOTHERAPY WITH OR WITHOUT PD-1 BLOCKADE IMPROVES ANTI-TUMOR T CELL RESPONSES IN SOLID TUMORS

被引：0
|
作者：
Axe, Dorothee Saddier [1 ]
Kuhne, Michelle [1 ]
Jain, Renu [1 ]
Weist, Brian [1 ]
机构：
[1] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0807
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
807
引用
收藏
页码：A843 / A843
页数：1
相关论文
共 50 条
  • [41] Blockade of PD-L1 signaling, but not depletion of regulatory T cells, delays tumor growth in a murine pancreatic tumor model
    Vohra, Nasreen A.
    Sarnaik, Amod
    Mackay, Amy
    Ghansah, Tomar
    Pilon-Thomas, Shari
    CANCER RESEARCH, 2011, 71
  • [42] COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
    Kyle Hansen
    Sandeep Kumar
    Kathryn Logronio
    Sarah Whelan
    Samir Qurashi
    Hsin-Yuan Cheng
    Andrew Drake
    Margaret Tang
    Patrick Wall
    David Bernados
    Ling Leung
    Eran Ophir
    Zoya Alteber
    Gady Cojocaru
    Moran Galperin
    Masha Frenkel
    Mark White
    John Hunter
    Spencer C. Liang
    Maya F. Kotturi
    Cancer Immunology, Immunotherapy, 2021, 70 : 3525 - 3540
  • [43] COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
    Hansen, Kyle
    Kumar, Sandeep
    Logronio, Kathryn
    Whelan, Sarah
    Qurashi, Samir
    Cheng, Hsin-Yuan
    Drake, Andrew
    Tang, Margaret
    Wall, Patrick
    Bernados, David
    Leung, Ling
    Ophir, Eran
    Alteber, Zoya
    Cojocaru, Gady
    Galperin, Moran
    Frenkel, Masha
    White, Mark
    Hunter, John
    Liang, Spencer C.
    Kotturi, Maya F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (12) : 3525 - 3540
  • [44] Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
    Banta, Karl L.
    Xu, Xiaozheng
    Chitre, Avantika S.
    Au-Yeung, Amelia
    Takahashi, Chikara
    O'Gorman, William E.
    Wu, Thomas D.
    Mittman, Stephanie
    Cubas, Rafael
    Comps-Agrar, Laetitia
    Fulzele, Amit
    Bennett, Eric J.
    Grogan, Jane L.
    Hui, Enfu
    Chiang, Eugene Y.
    Mellman, Ira
    IMMUNITY, 2022, 55 (03) : 512 - +
  • [45] Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
    Blank, C
    Kuball, J
    Voelkl, S
    Wiendl, H
    Becker, B
    Walter, B
    Majdic, O
    Gajewski, TF
    Theobald, M
    Andreesen, R
    Mackensen, A
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) : 317 - 327
  • [46] UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
    He, Chuan
    Xing, Xixin
    Chen, Hsin-Yi
    Gao, Minling
    Shi, Jie
    Xiang, Bolin
    Xiao, Xiangling
    Sun, Yishuang
    Yu, Haisheng
    Xu, Gaoshan
    Yao, Yingmeng
    Xie, Zuosong
    Xing, Yujie
    Budiarto, Bugi Ratno
    Chen, Shih-Yu
    Gao, Yang
    Lee, Yu-Ru
    Zhang, Jinfang
    MOLECULAR CELL, 2024, 84 (06) : 1120 - 1138.e8
  • [47] Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1T cell responses
    Santegoets, S. J.
    Duurland, C. L.
    Jordanova, E. S.
    van Ham, J. J.
    Ehsan, I.
    van Egmond, S. L.
    Welters, M. J. P.
    van der Burg, S. H.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [48] PD-1 blockade enhances synergistic killing of ovarian tumour cells by combination chemotherapy and T cell immunotherapy
    Wahba, J.
    Natoli, M.
    Whilding, L.
    Parente-Pereira, A.
    Maher, J.
    Smith, R.
    Ghaem-Maghami, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S218 - S218
  • [49] Targeting the ICOS pathway in combination with chemotherapy to enhance T-cell mediated anti-tumor immune responses
    Mahmoud, Tamer
    Riggs, Jeffrey
    Ramaswamy, Madhu
    Hostetler, Leigh
    Naiman, Brian
    Ramos, Ilyssa
    Turman, Sean
    Pilataxi, Fernanda
    Morehouse, Christopher
    Alfaro, Alex
    Peterson, Norman
    Fleming, Ryan
    Dimasi, Nazzareno
    Kuszpit, Kyle
    Herbst, Ronald
    Carlesso, Gianluca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [50] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345